Eye involvement in children with primary focal segmental glomerulosclerosis

被引:0
|
作者
Fatih Ozaltin
Saskia Heeringa
Ceren Erdogan Poyraz
Yelda Bilginer
Sibel Kadayifcilar
Nesrin Besbas
Rezan Topaloglu
Seza Ozen
Friedhelm Hildebrandt
Aysin Bakkaloglu
机构
[1] Hacettepe University Faculty of Medicine,Unit of Nephrology, Department of Pediatrics
[2] University of Michigan,Department of Pediatrics
[3] Hacettepe University Faculty of Medicine,Department of Ophthalmology
来源
Pediatric Nephrology | 2008年 / 23卷
关键词
Childhood; Focal segmental glomerulosclerosis; Eye; Steroid-resistant nephrotic syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
Distinct eye abnormalities have been described in children with nephrotic syndrome, particularly in diffuse mesangial sclerosis (i.e. Pierson syndrome). The aim of the study was to investigate whether there were any associated ocular anomalies in children with steroid-resistant nephrotic syndrome (SRNS), all of whom had revealed primary focal segmental glomerulosclerosis in biopsy. Thirty-three SRNS patients (16 male, 17 female) with a median age of 10.5 years (range 3–25 years) were enrolled in the study. Twenty steroid-sensitive nephrotic syndrome (SSNS) patients (ten male, ten female) with a median age of 8 years (range 3–15 years) served as controls. All SRNS patients were examined by mutational analysis for mutations in the NPHS2, WT1, and LAMB2 genes. Nine out of 33 SRNS patients (27.2%) showed various eye abnormalities. However, no abnormal ocular findings were detected in any of the SSNS patients. Abnormal eye findings detected in SRNS patients were anisometropic amblyopia (n = 4), Mittendorf’s dots (n = 4), myopic astigmatism (n = 3) and exotropia (n = 1). Macular pigment changes (n = 1), posterior subcapsular opacities (n = 1) and cataract (n = 1) were considered as steroid-induced side effects. In four patients, more than one eye abnormality was found. Mutational analysis for the NPHS2, WT1 and LAMB2 genes revealed disease-causing mutations in 24.2% of patients. Homozygous NPHS2 mutations were detected in five patients (15.1%), all of whom had parental consanguinity. In three patients (9%) from non-consanguineous parents, heterozygous de novo WT1 mutations were detected as disease-causing mutations. No LAMB2 mutation was detected in any patient. While four out of five (80%) patients with homozygous NPHS2 mutations showed at least one abnormal ocular finding (i.e. Mittendorf’s dot or anisometric amblyopia), none of the patients with a WT1 mutation had ocular involvement. In conclusion, ocular involvement may accompany SRNS caused by primary focal segmental glomerulosclerosis (FSGS). Ophthalmologic evaluation at the time of diagnosis might be beneficial to characterize further the spectrum of this possible association.
引用
收藏
页码:421 / 427
页数:6
相关论文
共 50 条
  • [21] Rituximab for refractory focal segmental glomerulosclerosis
    Makiko Nakayama
    Koichi Kamei
    Kandai Nozu
    Kentaro Matsuoka
    Atsuko Nakagawa
    Mayumi Sako
    Kazumoto Iijima
    Pediatric Nephrology, 2008, 23 : 481 - 485
  • [22] Rituximab for refractory focal segmental glomerulosclerosis
    Nakayama, Makiko
    Kamei, Koichi
    Nozu, Kandai
    Matsuoka, Kentaro
    Nakagawa, Atsuko
    Sako, Mayumi
    Iijima, Kazumoto
    PEDIATRIC NEPHROLOGY, 2008, 23 (03) : 481 - 485
  • [23] Focal segmental glomerulosclerosis – epidemiology aspects in children and adults
    Ronald Hogg
    John Middleton
    V. Matti Vehaskari
    Pediatric Nephrology, 2007, 22 : 183 - 186
  • [24] A Clinicopathologic Study of Children with Idiopathic Focal Segmental Glomerulosclerosis
    Nickavar, Azar
    Rahbar, Mahtab
    FETAL AND PEDIATRIC PATHOLOGY, 2016, 35 (03) : 159 - 166
  • [25] Kidney outcomes in children with primary focal segmental glomerulosclerosis from a low- and middle- income country
    Priyanka, Kolluri
    Deepthi, Bobbity
    Krishnasamy, Sudarsan
    Ganesh, Rajesh Nachiappa
    Sravani, Madhileti
    Krishnamurthy, Sriram
    PEDIATRIC NEPHROLOGY, 2024, 39 (12) : 3485 - 3495
  • [26] Outcomes of Steroid Treatment in Patients with Primary Focal Segmental Glomerulosclerosis
    Dervisoglu, Erkan
    Altun, Eda Arisoy
    Kalender, Betu
    Yilmiz, Ahmet
    Yildiz, Kursat
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2008, 17 (02): : 69 - 73
  • [27] Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis
    Zhang, Qingyan
    Zeng, Caihong
    Fu, Youjuan
    Cheng, Zhen
    Zhang, Jiong
    Liu, Zhihong
    NEPHROLOGY, 2012, 17 (04) : 338 - 345
  • [28] PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS - PATHOLOGY, HISTOLOGICAL VARIANTS, AND PATHOGENESIS
    SCHWARTZ, MM
    KORBET, SM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (06) : 874 - 883
  • [29] Primary focal segmental glomerulosclerosis in adults: is the Indian cohort different?
    Nada, Ritambhra
    Kharbanda, Jasleen Kaur
    Bhatti, Amulyajit
    Minz, Ranjana Walker
    Sakhuja, Vinay
    Joshi, Kusum
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (12) : 3701 - 3707
  • [30] PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS - CLINICAL COURSE AND RESPONSE TO THERAPY
    KORBET, SM
    SCHWARTZ, MM
    LEWIS, EJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (06) : 773 - 783